Meiji Seika Pharma's generic drug business enables wider treatment options for many common conditions, from infectious diseases and CNS disorders to digestive and lifestyle-related diseases. Our specialty and essential generics are made possible by expertise gained in new drug development. We're also actively engaged in contract manufacturing (CMO) and contract development and manufacturing (CDMO) in India, for Japan and overseas markets, to increase the availability of high-quality generic drugs worldwide.
Areas of Expertise
CMO & CDMO
Contract manufacturing (CMO) and contract development and manufacturing (CDMO) of generic drugs
Expanding Our Generic Drug Supply
In 2014, the Meiji Group welcomed Medreich Limited, a pharmaceutical manufacturer based in Bangalore, India, whose business includes contract manufacturing of generic drugs for sale in India and other markets. We later established Me Pharma to oversee our manufacturing and sales of generic drugs. The Meiji Group is now well placed to ensure a stable future supply of high-quality, low-cost generics for patients, while using Medreich's sales channels to expand our business in ASEAN and other regions.
Areas of Focus
Blood Plasma Products
Have a question?
Contact us here.
Meiji Seika Pharma Co., Ltd.
Based in Japan, we are a leading developer and manufacturer of antibacterial drugs, vaccines and biotech solutions, with a history of over 75 years.
2-4-16 Kyobashi, Chuo-ku, Tokyo104-8002 Japan